HBM: A Drug Target / Disease Biomarker (G3042)

Target Name: HBM

NCBI ID: G3042

Content of Review Report on HBM Target / Biomarker

HBM

HBM: A Drug Target / Disease Biomarker

Human bomb cyclin (HBM) is a protein that is expressed in various tissues of the body, including the brain, heart, kidneys, and gastrointestinal tract. It is a key regulator of cell proliferation and has been implicated in a number of diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases.

One of the key functions of HBM is its role in the regulation of cell proliferation. HBM contains a unique domain that is able to induce cell proliferation, while also able to inhibit the formation of blood vessels that could deliver oxygen and nutrients to newly formed cells. This dual function of HBM makes it an attractive drug target for researchers looking for new treatments for a variety of conditions.

In addition to its role in cell proliferation, HBM is also involved in the regulation of cell apoptosis, or programmed cell death. This is important because when cells are no longer needed or are damaged, they can undergo apoptosis to remove them from the body and prevent the formation of harmful new cells. HBM has been shown to play a key role in regulating cell apoptosis in a variety of tissues.

Another function of HBM is its role in the regulation of cell migration. This is important because cells have to move to different locations in the body in order to perform their functions, and HBM is involved in this process. HBM has been shown to play a key role in regulating the movement of blood vessels in the body, which is important for delivering oxygen and nutrients to new cells.

In addition to its functions in cell proliferation, apoptosis, and migration, HBM is also involved in the regulation of the immune response. This is important because the immune system is important for protecting the body against infection and disease. HBM has been shown to play a key role in regulating the movement of immune cells to the site of an infection or inflammation.

HBM is also involved in the regulation of cell adhesion. This is important because cells have to stick together in order to perform their functions, and HBM is involved in this process. HBM has been shown to play a key role in regulating the stickiness of cells to each other, which is important for the formation of tissues and organs.

In addition to its functions in cell proliferation, apoptosis, migration, and immune response, HBM is also involved in the regulation of the blood-brain barrier. This is important because the blood-brain barrier is the barrier that separates the brain from the rest of the body, and it is difficult for drugs to reach the brain. HBM has been shown to play a key role in breaking down the blood-brain barrier, which is important for the development of new treatments for neurological disorders.

In conclusion, HBM is a protein that is expressed in various tissues of the body and is involved in a number of important functions, including cell proliferation, apoptosis, migration, and immune response. Its unique domain has made it an attractive drug target for researchers looking for new treatments for a variety of conditions. Furthermore, HBM's role in regulating the blood-brain barrier makes it an important target for researchers studying the development of new treatments for neurological disorders.

Protein Name: Hemoglobin Subunit Mu

The "HBM Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about HBM comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets